Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) reported Friday a net income attributable to common shareholders for the fourth quarter of $27.49 million or $1.18 per share, compared to a net loss of $10.68 million or $0.55 per share in the prior-year quarter.
Excluding items, adjusted earnings for the quarter were $2.33 per share, compared to $1.63 per share in the year-ago quarter.
Total net revenues for the quarter grew 29.6 percent to $247.06 million from $190.57 million in the same quarter last year.
Looking ahead to fiscal 2026, the company continues to project adjusted earnings in the range of $8.83 to $9.34 per share on net revenues between $1.055 billion and $1.115 billion.
In Friday's pre-market trading, ANIP is trading on the Nasdaq at $83.00, up $5.85 or 7.58 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.